Skip to main content
OpenTrials
Completed

NCT Number: NCT03054805

The Effect of Probiotics on Constipation, and Intestinal Microflora in Children With Functional Constipation

To compare the differences of fecal microflora between constipated and non-constipated healthy children, and evaluate the efficacy of probiotics in reducing symptoms of constipation and the influence of intestinal microflora in children with functional constipation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–10 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

About this study

The investigators performed a monocentric, prospective, randomized controlled trial including 120 pediatric patients (aged 6 months - 10 years old) with functional constipation and 30 healthy age-matched healthy children as control. The investigators shall evaluate the children according to the Rome III Diagnostic Criteria for functional constipation.

The 120 enrolled patients are randomized in to two groups: Group A receiving magnesium oxide and probiotics (MIYAIRI-BM), Group B receiving only magnesium oxide. Each patient is assigned the evaluation constipation symptoms and detection of microflora (beneficial and harmful bacteria) in fecal samples at the enrollment, 4 weeks, and 12 weeks. Patients who take less than 80% of the appropriate dose of medications are withdrawn from the study. All patients included in the study will be given informed oral consent before entering the study.

The data of the fecal microflora evaluated in 60 healthy children are used as control.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Rome III Diagnostic Criteria for functional constipation for children aged 6 months - 4 years old is as the following:

  • Two or fewer defecations per week.
  • At least one episode per week of incontinence after acquiring toileting skills.
  • History of excessive stool retention.
  • History of painful or hard bowel movements.
  • Presence of a large fecal mass in the rectum.
  • History of large-diameter stools that may obstruct the toilet. Children aged 6 months - 4 years old is evaluated as functional constipation if two of the situations mentioned above lasted for one month.

Rome III Diagnostic Criteria for functional constipation for children aged 4 years old and above is as the following:

  • Two or fewer defecations in the toilet per week.
  • At least one episode of fecal incontinence per week.
  • History of retentive posturing or excessive volitional stool retention.
  • History of painful or hard bowel movements.
  • Presence of a large fecal mass in the rectum.
  • History of large diameter stools that may obstruct the toilet. Children aged 4 years old and above is evaluated as functional constipation if two of the situations mentioned above happens at least once per week

Exclusion criteria

  • gastroesophageal reflux disease
  • inflammatory bowel disease
  • cardiopulmonary diseases
  • liver disease
  • renal disease
  • genetic diseases
  • endocrinal diseases
  • received abdominal surgeries

Treatment and study plan

Magnesium oxide

Drug

Magnesium oxide 250 mg per day for children with weight < 15 kg, 500 mg per day for weight <15-30 kg, and 1000 mg per day for weight > 30 kg

Other names: MgO

MIYAIRI-BM

Drug

MIYAIRI-BM 1 g (1package) per day for children with weight < 15 kg, 2g per day for weight 15-30 kg, and 3g per day for weight > 30 kg

Other names: Clostridium Butyricum MIYAIRI

Primary outcomes

  1. Change of Clostridium Butyricum Miyairi Expression After Probiotics Supplementation in Constipated Children.

    Time frame: Change from baseline Clostridium butyricum Miyairi expression at 3 months.

    The expression of Clostridium butyricum Miyairi (CBM) in constipated children feces means a better outcome measure.

Sponsors and collaborators

Lead sponsor

Chang Gung Memorial Hospital

Other

Registry information

Important dates

Study start
2014
Primary completion
2014
Study completion
2016
First posted
Feb 16, 2017
Registry last updated
Aug 14, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.